Systemic Lupus Erythematosus: Unraveling the Immune System

Richard Furie, MD


October 19, 2022

Richard Furie, MD, surveys changes he has witnessed to the therapeutic landscape for the treatment of systemic lupus erythematosus (SLE), including the introduction of agents such as hydroxychloroquine and mycophenolate, belimumab, anifrolumab, and voclosporin.

Dr Furie contends that extended research supported the development of the current treatments for SLE, and that the arrival of new therapies will be made possible by continued advances in the understanding of the immune system.


Comments on Medscape are moderated and should be professional in tone and on topic. You must declare any conflicts of interest related to your comments and responses. Please see our Commenting Guide for further information. We reserve the right to remove posts at our sole discretion.